VI-RADS在膀胱癌中的应用:综述、要点与陷阱
本文综述了膀胱多参数MRI(mpMRI)及VI-RADS评分系统在膀胱癌术前T分期中的应用经验,通过病例回顾展示了VI-RADS 1至5类的影像特征,并讨论了日常报告中使用mpMRI和VI-RADS的实用要点与陷阱,旨在为放射科医生提供可及的参考。
要点
- VI-RADS用于膀胱癌mpMRI的标准化评分与报告,尤其适用于高危患者的术前T分期。
- 通过病例回顾展示了VI-RADS 1至5类的影像特征,便于日常报告对照使用。
- 文中讨论了使用mpMRI和VI-RADS的实用要点与陷阱,有助于提高报告准确性。
关键影像表现/征象
- 通过病例回顾展示了VI-RADS 1至5类对应的mpMRI影像特征。
- 讨论了膀胱癌mpMRI在治疗前评估中的成像特点。
诊断标准与关键数值
- VI-RADS评分系统于2018年制定,用于标准化膀胱癌mpMRI的成像与报告。
- VI-RADS分类包括1至5类,具体阈值和分级标准本文未详细列出。
临床应用与阅片要点
- 可将VI-RADS评分用于高危膀胱癌患者的术前T分期报告。
- 日常报告中使用mpMRI和VI-RADS时需注意文中讨论的实用要点与陷阱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Multiparametric magnetic resonance imaging (mpMRI) of the urinary bladder has shown high diagnostic performance in accurate staging of bladder cancer. Vesical Imaging Reporting and Data System (VI-RADS) scoring was developed in 2018 to standardize imaging and reporting of bladder cancer on mpMRI and is an excellent tool in preoperative T-staging of patients with high risk bladder cancer. However, there is no concise guide in the literature for practical use of VI-RADS in everyday clinical reporting. In this review, we describe our experience with mpMRI in pretreatment workup of bladder cancer, illustrate the imaging characteristics of VI-RADS categories 1 to 5 using case review, and discuss practical pearls and pitfalls in the use of mpMRI and VI-RADS in the hope of providing an accessible reference for radiologists in daily reporting.
引用
- Lai, Law. VI-RADS in bladder cancer: Overview, pearls and pitfalls. Eur J Radiol. 2023. PMID: 36689790. doi:10.1016/j.ejrad.2022.110666
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。